These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 10071274)

  • 61. Phase II Study of Nonmetastatic Desmoplastic Medulloblastoma in Children Younger Than 4 Years of Age: A Report of the Children's Oncology Group (ACNS1221).
    Lafay-Cousin L; Bouffet E; Strother D; Rudneva V; Hawkins C; Eberhart C; Horbinski C; Heier L; Souweidane M; Williams-Hughes C; Onar-Thomas A; Billups CA; Fouladi M; Northcott P; Robinson G; Gajjar A
    J Clin Oncol; 2020 Jan; 38(3):223-231. PubMed ID: 31774708
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Role of adjuvant chemotherapy in the treatment of medulloblastoma in children].
    Sachivko NV; Konoplia NE; Petrovich SV; Sharak EV
    Vopr Onkol; 2002; 48(3):318-21. PubMed ID: 12455354
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Management of medulloblastoma and ependymoma in infants: a single-institution long-term retrospective report.
    Massimino M; Gandola L; Cefalo G; Lasio G; Riva D; Fossati-Bellani F; Gianni MC; Luksch R; Tesoro-Tess JD; Lombardi F
    Childs Nerv Syst; 2000 Jan; 16(1):15-20. PubMed ID: 10672424
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study.
    Ris MD; Packer R; Goldwein J; Jones-Wallace D; Boyett JM
    J Clin Oncol; 2001 Aug; 19(15):3470-6. PubMed ID: 11481352
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Patterns of failure in supratentorial primitive neuroectodermal tumors treated in Children's Cancer Group Study 921, a phase III combined modality study.
    Hong TS; Mehta MP; Boyett JM; Donahue B; Rorke LB; Yao MS; Zeltzer PM
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):204-13. PubMed ID: 15337557
    [TBL] [Abstract][Full Text] [Related]  

  • 66. CNS-85 trial: a cooperative pediatric CNS tumor study--results of treatment of medulloblastoma patients.
    Pezzotta S; Cordero di Montezemolo L; Knerich R; Arrigoni M; Barbara A; Besenzon L; Brach del Prever A; Fidani P; Locatelli D; Loiacono G; Magrassi L; Perilongo G; Rigobello L; Urgesi A; Madon E
    Childs Nerv Syst; 1996 Feb; 12(2):87-96. PubMed ID: 8674087
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Phase II study of reduced-dose craniospinal irradiation and combination chemotherapy for children with newly diagnosed medulloblastoma: A report from the Japanese Pediatric Brain Tumor Consortium.
    Okada K; Soejima T; Sakamoto H; Hirato J; Hara J
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28572. PubMed ID: 32710713
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treatment of children with central nervous system primitive neuroectodermal tumors/pinealoblastomas in the prospective multicentric trial HIT 2000 using hyperfractionated radiation therapy followed by maintenance chemotherapy.
    Gerber NU; von Hoff K; Resch A; Ottensmeier H; Kwiecien R; Faldum A; Matuschek C; Hornung D; Bremer M; Benesch M; Pietsch T; Warmuth-Metz M; Kuehl J; Rutkowski S; Kortmann RD
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):863-71. PubMed ID: 24969797
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Local control in non-metastatic medulloblastoma.
    Christopherson KM; Bradley JA; Rotondo RL; Pincus DW; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
    Acta Oncol; 2014 Sep; 53(9):1151-7. PubMed ID: 24991891
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Preirradiation chemotherapy including "eight drugs in 1 day" regimen and high-dose methotrexate in childhood medulloblastoma: results of the M7 French Cooperative Study.
    Gentet JC; Bouffet E; Doz F; Tron P; Roche H; Thyss A; Plantaz D; Stephan JL; Mottolese C; Ponvert D
    J Neurosurg; 1995 Apr; 82(4):608-14. PubMed ID: 7897523
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Outcome and prognostic factors for children with supratentorial primitive neuroectodermal tumors treated with carboplatin during radiotherapy: a report from the Children's Oncology Group.
    Jakacki RI; Burger PC; Kocak M; Boyett JM; Goldwein J; Mehta M; Packer RJ; Tarbell NJ; Pollack IF
    Pediatr Blood Cancer; 2015 May; 62(5):776-83. PubMed ID: 25704363
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Disease control and ototoxicity using intensity-modulated radiation therapy tumor-bed boost for medulloblastoma.
    Polkinghorn WR; Dunkel IJ; Souweidane MM; Khakoo Y; Lyden DC; Gilheeney SW; Becher OJ; Budnick AS; Wolden SL
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e15-20. PubMed ID: 21481547
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I).
    Tait DM; Thornton-Jones H; Bloom HJ; Lemerle J; Morris-Jones P
    Eur J Cancer; 1990 Apr; 26(4):464-9. PubMed ID: 2141512
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment.
    Stensvold E; Krossnes BK; Lundar T; Due-Tønnessen BJ; Frič R; Due-Tønnessen P; Bechensteen AG; Myklebust TÅ; Johannesen TB; Brandal P
    Acta Oncol; 2017 May; 56(5):698-705. PubMed ID: 28325133
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The therapy of infantile malignant brain tumors: current status?
    Kalifa C; Grill J
    J Neurooncol; 2005 Dec; 75(3):279-85. PubMed ID: 16195802
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. A Pediatric Oncology Group study.
    Krischer JP; Ragab AH; Kun L; Kim TH; Laurent JP; Boyett JM; Cornell CJ; Link M; Luthy AR; Camitta B
    J Neurosurg; 1991 Jun; 74(6):905-9. PubMed ID: 2033450
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
    Geyer JR; Sposto R; Jennings M; Boyett JM; Axtell RA; Breiger D; Broxson E; Donahue B; Finlay JL; Goldwein JW; Heier LA; Johnson D; Mazewski C; Miller DC; Packer R; Puccetti D; Radcliffe J; Tao ML; Shiminski-Maher T;
    J Clin Oncol; 2005 Oct; 23(30):7621-31. PubMed ID: 16234523
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children's Oncology Group.
    Robertson PL; Muraszko KM; Holmes EJ; Sposto R; Packer RJ; Gajjar A; Dias MS; Allen JC;
    J Neurosurg; 2006 Dec; 105(6 Suppl):444-51. PubMed ID: 17184075
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone.
    Rutkowski S; Bode U; Deinlein F; Ottensmeier H; Warmuth-Metz M; Soerensen N; Graf N; Emser A; Pietsch T; Wolff JE; Kortmann RD; Kuehl J
    N Engl J Med; 2005 Mar; 352(10):978-86. PubMed ID: 15758008
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Results of combined treatment of cerebellar medulloblastomas in children with chemotherapy preceding radiotherapy].
    Roszkowski M; Barszcz S; Dramińska D; Grajkowska W; Wocjan J; Gardas-Skowrońska A
    Neurol Neurochir Pol; 1994; 28(5):719-32. PubMed ID: 7862239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.